Abstract
The bioartificial pancreas presents a promising methodology to treat diabetes. However, this approach is still associated with a high rate of graft failure caused by poorly functioning cells. The incretin effect of glucagon like peptide-1 (GLP-1) make this peptide an attractive therapeutic agent to improve the success of transplantation of encapsulated beta cells. In present work, we developed a novel model based on the co-encapsulation of beta cells with nanoparticles containing GLP-1 on alginate hydrogels, allowing its delivery and action in the specific target, the beta cells.
INS-1E beta cells were co-encapsulated with poly(lactide-co-glycolide) (PLGA) nanoparticles containing GLP-1 in alginate and were maintained in culture aiming to evaluate the performance of our drug-delivery system and the influence of GLP-1 in cellular performance.
PLGA nanoparticles showed an average size of 169.3 nm, a polydispersity index of 0.05 and an average zeta-potential of −24.3 mV. The average association efficiency of GLP-1 was 65.4% and the in vitro release test showed 71% of GLP-1 delivery after 7 days. The presence of nanoparticles led to increased cellular metabolic activity and 8-fold higher insulin levels. Our results reveal a promising approach to ensure the proper delivery and action of GLP-1 in encapsulated beta cells, ensuring its viability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Crisóstomo, J., Coelho, J., Seiça, R.: Bioartificial pancreas: in the road to clinical application. In: Coelho, J. (ed.) Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment, pp. 127–151. Springer, Dordrecht (2013)
Sun, J., Tan, H.: Alginate-based biomaterials for regenerative medicine applications. Materials 6(4), 1285–1309 (2013)
Wilson, J.T., Chaikof, E.L.: Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv. Drug Deliv. Rev. 60, 124–145 (2008)
Brubaker, P., Drucker, D.: Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145, 2653–2659 (2004)
Puddu, A., Sanguineti, R., Mach, F., Dallegri, F., Viviani, G.L., Montecucco, F.: Update on the protective molecular pathways improving pancreatic beta-cell dysfunction. Mediators Inflamm. 2013, 750540 (2013)
Holst, J.J.: The Physiology of Glucagon-like Peptide 1. Physiol. Rev. 87, 1409–1439 (2007)
Toyoda, K., Okitsu, T., Yamane, S., Uonaga, T., Liu, X., Harada, N., et al.: GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis. Biochem. Biophys. Res. Commun. 367, 793–798 (2008)
Bohman, S., Waern, I., Andersson, A., King, A.: Transient beneficial effects of exendin-4 treatment on the function of microencapsulated mouse pancreatic islets. Cell Transplant. 16, 15–22 (2007)
Kim, S., Wan Kim, S., Bae, Y.H.: Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials 26, 3597–3606 (2005)
Lin, C.C., Anseth, K.S.: Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells. Biomacromolecules 10, 2460–2467 (2009)
Chepurny, O.G., Holz, G.G.: Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation. Cell Tissue Res. 307, 191–201 (2002)
Kim, S., Bae, Y.: Long-term insulinotropic activity of glucagon-like peptide-1/polymer conjugate on islet microcapsules. Tissue Eng. 10, 1607–1616 (2004)
Sadat, T.M., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M.R., Milani, M., Zarghami, N., et al.: PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac. J. Cancer Prev. 15, 517–535 (2014)
Araújo, F., Shrestha, N., Shahbazi, M.-A., Fonte, P., Mäkilä, E.M., Salonen, J.J., et al.: The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium. Biomaterials 35, 9199–9207 (2014)
Bidarra, S., Barrias, C., Barbosa, M., Soares, R., Granja, P.: Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential. Biomacromolecules 11, 1956–1964 (2010)
Crisóstomo, J., Pereira, A.M., Bidarra, S.J., Gonçalves, A.C., Granja, P.L., Coelho, J., et al.: ECM-enriched alginate hydrogels for bioartificial pancreas: an ideal niche to improve insulin secretion and diabetic glucose profile. J. Appl. Biomater. Funct. Mater. (in press)
de Vos, P., Faas, M.M., Strand, B., Calafiore, R.: Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 27, 5603–5617 (2006)
Qi, M.: Transplantation of encapsulated pancreatic islets as a treatment for patients with Type 1 Diabetes Mellitus. Adv. Med. 2014, 429710 (2014)
Luo, G., Kong, X., Lu, L., Xu, X., Wang, H., Ma, X.: Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets. Int. J. Biochem. Cell Biol. 45, 483–490 (2013)
Acknowledgements
The present work is a collaboration between IBILI and INEB, supported by grants UID/NEU/04539/2013, UID/BIM/04293/2013 and SFRH/BD/72964/2010.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
The authors report no conflicts of interest.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Crisóstomo, J., Araújo, F., Granja, P., Barrias, C., Sarmento, B., Seiça, R. (2020). Co-encapsulation of Beta Cells and Nanoparticles Containing GLP-1 Greatly Improves Insulin Secretion in Alginate-Based Bioartificial Pancreas. In: Henriques, J., Neves, N., de Carvalho, P. (eds) XV Mediterranean Conference on Medical and Biological Engineering and Computing – MEDICON 2019. MEDICON 2019. IFMBE Proceedings, vol 76. Springer, Cham. https://doi.org/10.1007/978-3-030-31635-8_147
Download citation
DOI: https://doi.org/10.1007/978-3-030-31635-8_147
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-31634-1
Online ISBN: 978-3-030-31635-8
eBook Packages: EngineeringEngineering (R0)